The overall objective of this proposal continues to be to define the critical cellular mechanisms culminating in lethal liver cell injury. Because of the importance of cholestatic liver injury in human disease, our program is working on the cellular mechanisms causing hepatocyte injury during cholestasis. Specifically, our long-term goal is to understand the cellular mechanisms by which bile salts, which accumulate in the liver during cholestasis, modulate hepatocyte apoptosis. Based on our preliminary data, we propose the novel CENTRAL HYPOTHESIS that hvdrophobic hepatotoxic bile salts induce hepatocvte apoptosis by a Fas-dependent mechanism while more hydrophilic bile salts inhibit apoptosis by actively stimulating a phosphoinositide 3-kinase (PI3K)-dependent survival pathway. We will now employ current and complementary molecular, biochemical, and cell biological approaches to ascertain how bile salts modulate apoptotic effector processes. Our proposal has three SPECIFIC AIMS. FIRST, we will directly test the hypothesis that toxic bile salts induce hepatocyte apoptosis by a Fas-dependent process resulting in: a) Fas oligomerization independent of Fas ligand; and b) formation of a death-inducing signaling complex (DISC) with caspase 8 activation. SECOND, we will test the hypothesis that toxic bile salts increase plasma membrane Fas receptors: a) by a mechanism dependent upon a redistribution of pre-existing cytoplasmic Fas to the plasma membrane via a microtubule-dependent transport pathway; and b) resulting in a mechanism of apoptosis dependent upon intracellular Fas translocation to the cell surface. FINALLY, non toxic, hydrophilic bile salts directly signal cell survival pathways by a phosphoinositide 3-kinase (PI3K)-dependent mechanism resulting in: a) activation of the antiapoptotic atypical protein kinase c isoforms (PKC? and PKCX.); and b) inhibition of apoptosis by atypical PKC-dependent activation of nuclear factor kappa B (NF-KB) and/or caspase phosphorylation. The proposal is innovative conceptually and technically as it tests new concepts for both bile salt-mediated cytotoxicity and apoptosis in general using sophisticated methodologies. The significance of the information generated is that it will help provide a framework for the potential development of novel therapeutic strategies effective in attenuating cholestatic liver injury.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37DK041876-20
Application #
7404382
Study Section
Special Emphasis Panel (NSS)
Program Officer
Doo, Edward
Project Start
1992-09-30
Project End
2010-03-31
Budget Start
2008-04-01
Budget End
2009-03-31
Support Year
20
Fiscal Year
2008
Total Cost
$311,520
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905
Ibrahim, Samar H; Hirsova, Petra; Gores, Gregory J (2018) Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammation. Gut 67:963-972
Loarca, Lorena; De Assuncao, Thiago M; Jalan-Sakrikar, Nidhi et al. (2017) Development and characterization of cholangioids from normal and diseased human cholangiocytes as an in vitro model to study primary sclerosing cholangitis. Lab Invest 97:1385-1396
Greuter, Thomas; Malhi, Harmeet; Gores, Gregory J et al. (2017) Therapeutic opportunities for alcoholic steatohepatitis and nonalcoholic steatohepatitis: exploiting similarities and differences in pathogenesis. JCI Insight 2:
Hirsova, Petra; Guicciardi, Maria Eugenia; Gores, Gregory J (2017) Proapoptotic signaling induced by deletion of receptor-interacting kinase 1 and TNF receptor-associated factor 2 results in liver carcinogenesis. Hepatology 66:983-985
Hirsova, Petra; Ibrahim, Samar H; Krishnan, Anuradha et al. (2016) Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes. Gastroenterology 150:956-67
Bergquist, John R; Ivanics, Tommy; Storlie, Curtis B et al. (2016) Implications of CA19-9 elevation for survival, staging, and treatment sequencing in intrahepatic cholangiocarcinoma: A national cohort analysis. J Surg Oncol 114:475-82
Ibrahim, Samar H; Hirsova, Petra; Tomita, Kyoko et al. (2016) Mixed lineage kinase 3 mediates release of C-X-C motif ligand 10-bearing chemotactic extracellular vesicles from lipotoxic hepatocytes. Hepatology 63:731-44
Hirsova, Petra; Ibrahim, Samar H; Verma, Vikas K et al. (2016) Extracellular vesicles in liver pathobiology: Small particles with big impact. Hepatology 64:2219-2233
Verma, Vikas K; Li, Haiyang; Wang, Ruisi et al. (2016) Alcohol stimulates macrophage activation through caspase-dependent hepatocyte derived release of CD40L containing extracellular vesicles. J Hepatol 64:651-60
Hirsova, Petra; Ibrahim, Samar H; Gores, Gregory J et al. (2016) Lipotoxic lethal and sublethal stress signaling in hepatocytes: relevance to NASH pathogenesis. J Lipid Res 57:1758-1770

Showing the most recent 10 out of 42 publications